SUSANA
BARRENA DELFA
Investigadora
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaInstituto de Investigación Biomédica de Salamanca-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2024
-
A novel NKp80-based strategy for universal identification of normal, reactive and tumor/clonal natural killer-cells in blood
Frontiers in Immunology, Vol. 15
-
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study
Cytometry Part B - Clinical Cytometry, Vol. 106, Núm. 4, pp. 252-263
2022
-
ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S199
-
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study
British Journal of Haematology, Vol. 197, Núm. 1, pp. 76-81
2021
-
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study
Modern Pathology, Vol. 34, Núm. 1, pp. 59-69